Sanofi, which is joining a growing number of ... Opella employs 11,000 people globally and sells popular French pain medicine Doliprane, as well as brands including Mucosolvan cough syrup, Allegra ...

Insilico Medicine (“Insilico”), a clinical-stage generative artificial intelligence (AI)-driven biotechnology company, today ...

Healx will use its AI-based drug discovery tech to analyze proprietary Sanofi compound data and identify potential rare disease targets.

Sarclisa recommended for EU approval by the CHMP to treat transplant-ineligible newly diagnosed multiple myelomaRecommendation based on IMROZ ...

Attorneys for the school district say that the legal action is in part due to self-funded insurance plans that has possibly ...

Emanuele de Rinaldis, global head of precision medicine and computational biology at Sanofi, commented: “[O]ur drug discovery strategy is driven by precision medicine. We seek to describe ...

Sanofi has unveiled a new alliance with Duke University and the Massachusetts General Hospital to mine big data to try to predict which patients will adhere to their medication – and which won't.

This agreement follows Sanofi’s announcement of an exclusive ... This novel precision medicine approach aims at changing the standard of care in some rare cancers to extend patients’ lives ...

Sanofi, through its philanthropic organisation Foundation S, is celebrating the 25th anniversary of The Gaucher Initiative, a ...

Brad Lightcap, COO, OpenAI "We believe AI can accelerate drug development, bringing new treatments to patients more quickly. This first product from our collaboration with Sanofi and Formation Bio is ...

T1D is an autoimmune, complex, and lifelong condition – and it can happen to anyone at any age even without family history.[1 ...

Dupixent approved in the EU as the first and only medicine for young children with eosinophilic esophagitisApproval based on phase 3 data showing ...